Paul A. Gurbel, MD

Paul Gurbel

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Bayer (SIGNIFICANT), Wolters Kluwer(MODEST), Cleveland Clinic(MODEST), Web MD Medscape(SIGNIFICANT), Medforce(MODEST) RESEARCH/RESEARCH GRANTS: Instrumentation Labs(SIGNIFICANT), Hikari Dx(SIGNIFICANT), Novartis Corporation(SIGNIFICANT), LabCorp Drug Development(SIGNIFICANT), Idorsia(SIGNIFICANT), Prolocor(MODEST), Recor(SIGNIFICANT), Recor Medical(SIGNIFICANT), Haemonetics(SIGNIFICANT), Eli Lilly and Company(SIGNIFICANT), Bayer Healthcare Pharmaceuticals(SIGNIFICANT), BMS(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Baron and Bud(SIGNIFICANT)

View Full Disclosure